All Stories

  1. Assessment of cognitive–motor functions in adults with perceived neuropsychological problems using NIH toolbox after remote biofield energy treatment as non‐pharmacological intervention: A randomized double‐blind placebo controlled trial
  2. Effects of distant biofield energy healing on adults associated with psychological and mental health-related symptoms: a randomized, placebo-controlled, double-blind study
  3. The use of biofield energy therapy as complementary and alternative medicine in human health care system: a narrative review and potential mechanisms
  4. Quantum Biofield Energy Therapy for Psychological and Mental Health Problems
  5. Cannabidiol (CBD) Upregulates Vitamin D3 Receptors (VDRs) Expression That Modulates Cytokines (TNF-α, IL-6), Tissue Elasticity, Cellular Senescence, and Mitochondrial ATP Generation in Human and Rodent Cell Lines
  6. Vitamin D3 Supplementation: Improving Memory, Muscle Function, and Pain in Deficient Rats
  7. Simultaneous identification and quantification of pentacyclic triterpenoids and phenolic compounds from the leaves of Boswellia serrata using LC–MS/MS tandem mass spectrometry
  8. The role of biofield energy treatment on psychological symptoms, mental health disorders, and stress‐related quality of life in adult subjects: A randomized controlled clinical trial
  9. Efficacy of a novel proprietary dietary supplement (TRI 360TM) on psychological symptoms and stress-related quality of life in adult subjects: A randomized controlled clinical trial
  10. Impact on Fundamental Physiological Functional Biomarkers after Administration of Biofield Treated Formulation in Unpredictable Chronic Stress (UCS)-Induced Rats
  11. Evaluation of Anti-inflammatory Activity after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  12. Evaluation of Inflammatory Serum Cytokines after Treatment with the Consciousness Energy Healing Based Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. Coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley...
  13. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Brain Tissues in Cecal Slurry, LPS and E. Coli-Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  14. Evaluation of Cardiac Performance after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  15. Evaluation of Antioxidative Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  16. Elasticity Profile of Skin, Neuronal, Cardiac, and Skeletal Muscle Cells after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation
  17. Oxidative Stress and Inflammatory Biomarkers Analysis of Biofield Treated Proprietary Test Formulation in Heart Tissues in Cecal Slurry, LPS and E. Coli-induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  18. Anti-Inflammatory Activity of Biofield Energy Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  19. Evaluation of Immunomodulatory Effect of a Novel Test Formulation in D-Galactose-Induced Aging Dysfunction in Sprague Dawley Rats
  20. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Intestinal Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  21. Evaluation of Renal and Cardioprotective Potential of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  22. LC-MS and GC-MS-Based Assessment of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios of Sulfamethoxazole
  23. Structural Characterization and Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Ofloxacin
  24. Effect of Biofield Treatment on Blood, Hepatic, and Cardiac Biomarkers in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  25. Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
  26. Study of the Consciousness Energy Healing Treatment and It’s Effect on the Isotopic Abundance Ratio of Ascorbic Acid (Vitamin C)
  27. Evaluation of the Isotopic Abundance Ratio of Consciousness Energy Healing Treated L-Tryptophan Using LC-MS Spectrometry
  28. Effect of Consciousness Energy Healing Treatment on the Metal Profile and Properties of Tellurium
  29. Antioxidant Activity of Biofield Treated Proprietary Test Formulation Supplemented with Vitamins and Minerals in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  30. Evaluation of Vitamin D3 metabolite (25-OH Vit D3), Neurotransmitter (ACh), and the Expression of Proinflammatory Cytokines (IL-6 and TNF-α) in Tissue Homogenate after Administration of Biofield Energy Healing-based Novel Proprietary Test Formulation a...
  31. Liquid Chromatography-Mass Spectrometry Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated L-Cysteine
  32. "A Comprehensive Study of Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Berberine Chloride Using LC-MS and GC-MS"
  33. sotopic Abundance Ratio Evaluation of the Consciousness Energy Treated Pyridoxine Using LC-MS and GC-MS Spectrometry
  34. "Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid"
  35. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of L-Cysteine Using LC-MS Spectrometry
  36. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Folic Acid Using LC-MS Spectrometry
  37. Influence of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  38. Impact of Biofield Energy Healing Treatment on the Isotopic Abundance Ratio Analysis of Pyridoxine HCl Using LC-MS and GC-MS Spectrometry
  39. Identification of Endothelin-1 and Nitric Oxide Activity in Aorta, Lung and Kidney after Treatment with the Biofield Energy Treated Proprietary Test Formulation on L-Name and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  40. Evaluation of Inflammatory Response after Treatment with the Biofield Energy Treated Proprietary Test Formulation on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  41. Neuroprotective (iNOS), fibrinolytic (FDP) Markers Analysis of Biofield Treated Proprietary Test Formulation on Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) Model in Sprague Dawley Rats
  42. Evaluation of Inflammatory Serum Biomarkers after Treatment with the Consciousness Energy Healing-Based Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  43. Study of VDR Expression after Treatment with the Biofield Energy Healing-Based Proprietary Test Formulation Using Cellular Models
  44. Estimation of Sex Hormone, Blood Profiling, and Histopathological Analysis after Treatment with the Biofield Energy Treated Proprietary Test Formulation in Unpredictable Chronic Stress (UCS)- Induced Sprague Dawley Rats
  45. Study of Behavioral Parameters in Vitamin D3 Deficiency Diet (VDD) Induced Animal Model: An Influence of Biofield Energy Healing Treatment
  46. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Sulfamethoxazole Using LC-MS and GC-MS Spectrometry
  47. The LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Silver Sulfadiazine
  48. Isotopic Abundance Ratio Analysis of the Consciousness Energy Healing Treated Flutamide using LC-MS and GC-MS Spectrometry
  49. Evaluation of Cardiac Biomarkers after Administration of the Biofield Energy Treated Proprietary Test Formulation on L-NAME and High Fat Diet-Induced Cardiovascular Disorders in Sprague Dawley Rats
  50. Evaluation of Stress Biomakers (Cytokines) in Presence of Unpredictable Chronic Stress (UCS) in Sprague Dawley Rats after Treatment with the Biofield Energy Treated Novel Proprietary Test Formulation
  51. Effects of Consciousness Energy Healing Treatment on the Improvement of Relative Oral Bioavailability of Low Bioavailable Resveratrol in Male Sprague Dawley Rats
  52. The Isotopic Abundance Ratio of Consciousness Energy Treated L-Tryptophan Using LC-MS Spectrometry
  53. Influence of the Biofield Energy Treatment on the Pharmacokinetics of 25-Hydroxyvitamin D3 in Male Sprague-Dawley Rats after a Single Oral Dose of Vitamin D3
  54. The Biofield Energy Treatment and its Effect on the Relative Oral Bioavailability of Lovastatin Hydroxy Acid in Rats after a Single Oral Dose of Lovastatin
  55. Antioxidant and Anti-Inflammatory Activities of Biofield Energy Treated Proprietary Test Formulation in Lungs Tissues on Combination of Cecal Slurry, LPS and E. coli Induced Systemic Inflammatory Response Syndrome (SIRS) in Sprague Dawley Rats
  56. LC-MS and GC-MS Based Isotopic Abundance Ratio Analysis of Consciousness Energy Healing Treated Ofloxacin
  57. Analysis of Isotopic Abundance Ratio of Consciousness Energy Healing Treated Metronidazole Using LC-MS and GC-MS Spectrometry
  58. Assessment of Neurobehavioral and Anti-Aging Effect of the Test Formulation in D-Galactose-Induced aging Dysfunction in Sprague Dawley Rats
  59. Prevention of Aging and Improvement of Longevity and Life-Span in D-Galactose Induced Aging Rats After Treatment with the Biofield Energy Per Se and Biofield Treated Proprietary Test Formulation
  60. Gas Chromatography and Mass Spectroscopy (GC-MS) Based Isotopic Abundance Ratio Evaluation of the Biofield Energy Treated Metronidazole
  61. Effect of the Biofield Energy Treated Proprietary Test Formulation for Sleep Biomarkers in the Unpredictable Chronic Stress (UCS) Animal Model
  62. Antiaging, Cognition and Anti-Inflammatory Potential of the Biofield Energy Treatment in Vitamin D3 Deficiency Diet (VDD) Induced Sprague Dawley Rats
  63. Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratio of Cefazolin Sodium Using LC-MS and GC-MS Spectrometry
  64. Improvement of Vitamin D 3 Metabolites Level after Oral Administration of the Biofield Energy Treated Proprietary Test Formulation in Vitamin D 3 Deficiency Diet (VDD) Induced Rat Model
  65. Evaluation of the Impact of Consciousness Energy Healing Treatment on the Isotopic Abundance Ratios (PM+1/PM and PM+2/PM) of Ofloxacin
  66. Influence of Consciousness Energy Healing Treatment on the Properties of Polylactic-co- Glycolic Acid (PLGA)
  67. Characterization of the biofield energy treated aluminium using PSA, PXRD, and TGA/DTG analytical techniques
  68. Consciousness Energy Healing Treatment Influenced the Physicochemical Properties of Zinc
  69. "Evaluation of Physicochemical and Thermal Properties of the Consciousness Energy Healing Treated Tellurium"
  70. In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
  71. Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
  72. Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
  73. Antioxidant and Organ Protective Potential of the Consciousness Energy Healing-Based Novel Test Formulation Using Different Biomarkers Analysis
  74. "Assessment of the Biofield Energy Healing Based Test Formulation on Human Organ Health Specific Biomarkers In Vitro Assays"
  75. Powder X-ray Diffraction and Particle Size Analysis of the Consciousness Energy Healing Treated Vanadium Pentoxide (V2O5)
  76. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Zinc
  77. Consciousness Energy Healing Treatment: Physicochemical and Thermal Characterization of Magnesium
  78. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Properties of Pyridoxine HCl
  79. Complementary and Alternative Medicine: Impact of Consciousness Healing Treatment on the Characteristic Properties of Sulfamethoxazole
  80. Physicochemical and Thermal Characterization of Ascorbic Acid: Impact of Biofield Energy Treatment
  81. Physicochemical and Thermal Characterization of the Consciousness Energy Healing Treated Folic acid
  82. Evaluation of Stress Biomarkers after Oral Administration of the Consciousness Energy Healing Treated Novel Herbomineral Formulation in Male Sprague Dawley Rats
  83. Solid State Characterization of the Consciousness Energy Healing Treated Magnesium
  84. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Cefazolin Sodium
  85. Evaluation of a Consciousness Energy Healing Based Test Formulation for Skin Health
  86. Complementary and Alternative Medicine: Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Treated Metronidazole
  87. Solid State Characterization for a Comparative Evaluation of the Biofield Energy Treated and Un-treated Ascorbic Acid
  88. Evaluation of the Physicochemical and Thermal Properties of Folic Acid: Influence of the Energy of Consciousness Healing Treatment
  89. Evaluation of Estrogenic Activity of Biofield Energy Treatment for the Potential of Menstrual Disorders Using Ishikawa Cell Line
  90. Flutamide: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Characteristics
  91. Complementary and Alternative Medicine: Evaluation of the impact of Biofield Energy Treatment on L-Cysteine
  92. Spectroscopic and Calorimetric Evaluation of the Biofield Energy Healing Treated Ofloxacin
  93. Effect of the Consciousness Energy Healing Treatment on the Characteristic Properties of Cefazolin Sodium
  94. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Cholecalciferol (Vitamin D3)
  95. Biofield Energy Treatment: Physicochemical and Thermal Characterization of L-Tryptophan
  96. Consciousness Energy Healing Treatment: Spectroscopic and Calorimetric Evaluation of the Biofield Energy Treated Hydroxypropyl β-Cyclodextrin
  97. Anti-Rheumatoid Arthritis (RA) Action of Biofield Energy Treatment Using Synovial Sarcoma Cell Line (SW982)
  98. Assessment of Anti-Ageing Potential of Consciousness Energy Healing Treated DMEM and HFF-1 Cells using Cellular Proliferation and Collagen Metabolism Assays
  99. Characterization of the Physicochemical and Thermal properties of the Biofield Energy Treated Flutamide Using PSA, PXRD, TGA/DTG, and DSC Analytical Techniques
  100. Particle Size, Surface Area, Crystallite Size, and Thermal Analysis of Consciousness Energy Healing Treated Selenium
  101. Assessment of the Physicochemical and Thermal Characterization of Biofield Energy Treated Polylactic-co-glycolic acid (PLGA)
  102. Complementary and Alternative Medicine: Impact of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Withania somnifera Root Extract
  103. Biofield Energy Treatment Based Test Formulation as a Novel and Efficient Approach on Various Biomarkers in human Bones, Heart, Liver, Lungs, and Brain Cells
  104. Investigation of Vital Organ Specific Biomarkers Using CellBased Assays after Treatment with the Biofield Energy Treated Test Formulation
  105. Study of the Effect of Consciousness Energy Healing Treatment on the Natural Product Berberine Chloride
  106. Evaluation of the Outcome of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Magnesium
  107. Impact of the Trivedi Effect® on the Physicochemical Properties of Antimony
  108. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of an Anticancer Drug 6-Mercaptopurine
  109. Biofield Energy Therapy: Role in Multiple Organ Health Specific Biomarkers in Cell-Based Assay
  110. Physicochemical and Thermal Characterization of Consciousness Energy Healing Treated Copper (II) Chloride Using PXRD, DSC, and TGA/DTG
  111. Powder XRD, PSD and DSC Analysis of the Consciousness Energy Healing Treated Zinc Chloride
  112. Evaluation of the Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  113. Consciousness Energy Healing Treatment: Impact on Physicochemical and Thermal Properties of Silver Sulfadiazine
  114. Wound Healing Activity of Consciousness Energy Healing Treatmenton HFF-1 Cells and DMEM Using Scratch Assay
  115. Evaluation of the Consciousness Energy Healing Treated Berberine Chloride Using PXRD, PSA, and DSC Analysis
  116. Complementary and Alternative Medicine: Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of 6-Mercaptopurine
  117. The Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Silver Oxide (Ag2O)a
  118. In Vitro Assessment of Biofield Energy Healing Treatment on Hair Growth by Enhanced Proliferation of Human Follicular Dermal Papilla Cells (HFDPCs)
  119. In vitro Assessment of Biofield Energy Treated DMEM on Thermogenesis Using Myoblasts Cell Line (C2C12)
  120. Assessment of Biofield Energy Treatment on Liver Health Using Hepatocellular Carcinoma Cell Line (HepG2)
  121. Influence of the Biofield Energy Therapy on the Physicochemical and Thermal Properties of Sulfamethoxazole
  122. Assessment of the Influence of Biofield Energy Treatment on the Physicochemical and Thermal Properties of Lead Using PXRD, PSA, and DSC
  123. Evaluation of the Physicochemical and Thermal Properties of Chromium Trioxide (CrO3): Impact of Consciousness Energy Healing Treatment
  124. Consciousness Energy Healing Treatment: Impact on the Physicochemical and Thermal Characteristics of Folic Acid
  125. Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  126. An Investigation of the Consciousness Energy Healing Therapy on Physicochemical and Thermal Properties of Silver Sulfadiazine
  127. Antioxidative Potential of Consciousness Energy Healing Treatment on HepG2 Cells and DMEM after Oxidative Stress Induced by Hydrogen Peroxide
  128. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Silver Oxide
  129. Effect of the Consciousness Energy Healing Treatment on DMEM for the Proliferation and Differentiation of Human Bone Osteosarcoma Cells to Improve Bone Health
  130. Antiaging Potentia
  131. Evaluation of the Physicochemical and Thermal Properties of the Biofield Energy Healing Treated Ofloxacin
  132. Antiaging Potential of Consciousness Energy Healing-Based Novel Proprietary Formulation
  133. Role of Vitamin D3 on Bone Health in Human Bone Osteosarcoma Cells (MG-63): Influence of Biofield Energy Healing Treatment
  134. Impact of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Vitamin D3 (Cholecalciferol)
  135. The Effect of Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of L-Cysteine
  136. The Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of 6-Mercaptopurine
  137. Consciousness Energy Healing Treatment on the Physicochemical and Thermal Properties of Selenium
  138. Evaluation of the Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Lead Using PXRD, PSA, and DSC Analysis
  139. Assessment of Biofield Energy Healing Based Vitamin D3 Effects on Bone Health Parameters
  140. Biofield Energy Treated Vitamin D3 on the Structural Crosslinks, Maturation, and Bone Mineralization
  141. Assessment of Energy of Consciousness Healing on Cell Growth of Plant Stem Cells Callus Culture
  142. "A Comparative Analysis of Vitamin D3 and Biofield Energy Treated Vitamin D3 in Bone Health Using MG-63 Cell Line"
  143. Increase in Bone Mass Density and Overall Bone Health Following High-Impact of Bio-field Energy Treated Vitamin D3inMG-63 Cell Line
  144. Biofield Energy Enriched Vitamin D3 versus Vitamin D3 in Preventing Fractures and Bone Loss
  145. Functional Modification of Bone Tissues After Treatment with the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  146. Role of Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63): A Multidisciplinary Aspect on Bone Health
  147. Vitamin D3 and Consciousness Energy Healing TreatmentModality on Human Osteoblast Cells
  148. The Bone Regenerative Effects of the Biofield Energy Treated Vitamin D3 in Human Bone Osteosarcoma Cells (MG-63)
  149. Biofield Energy Healing Based Vitamin D3: An Improved Overall Bone Health Activity in MG-63 Cell Line
  150. Influence of the Biofield Energy Treated Vitamin D<sub>3</sub> on Human Osteoblast-Like Cells
  151. Effect of Biofield EnergyTreated Vitamin D3 on the Proliferation of Osteoblast-Like MG-63 Human Osteosarcoma Cells in vitro
  152. Biofield Energy Based Vitamin D<sub>3</sub> Stimulates <i>In vitro</i> Osteoblasts Differentiation in MG-63 Cell line
  153. An <i>In vitro</i> Experiment on Bone Growth and Differentiation in Human Bone Osteosarcoma Cells (MG-63): Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  154. Assessment of Bone Health After Treatment with the Consciousness Energy Healing Treated Vitamin D<sub>3</sub> in Human Bone Osteosarcoma Cells (MG-63)
  155. Biofield Energy Enriched Vitamin D<sub>3</sub>: A New Horizons for Development of Bone Health Using MG-63 Cells
  156. Regulation of Bone Health Parameters After Treatment with Biofield Energy Healing Based Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63)
  157. <i>In vitro</i> Study on Human Bone Osteosarcoma Cells (MG-63): Role of Biofield Energy Treated Vitamin D<sub>3</sub>
  158. Biofield Energy Treated Vitamin D<sub>3</sub>: Therapeutic Implication on Bone Health Using Osteoblasts Cells
  159. The Influence of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health and Its Health Consequences in MG-63 Cell-Line
  160. Effect of Biofield Energized Vitamin D<sub>3</sub> on Bone Health in MG-63 Cell-Line
  161. Regulation of Bone Health Parameters in MG-63 Cell Line After Treatment with Biofield Energy Treated Vitamin D<sub>3</sub>
  162. The Effect of Vitamin D<sub>3</sub> on Bone Mineralization: Influence of Consciousness Energy Healing Treatment
  163. Evaluation of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Health Parameters in Human Bone Osteosarcoma Cells (MG-63)
  164. Influence of Biofield Treated Vitamin D<sub>3</sub> on Proliferation, Differentiation, and Maturation of Bone-Related Parameters in MG-63 Cell-Line
  165. A Perspective of Bone Health Study: Impact of Biofield Energy Treated Vitamin D<sub>3</sub>
  166. Influenced of Biofield Energy Healing Treatment on Vitamin D<sub>3</sub> for the Assessment of Bone Health Parameters in MG-63 cells
  167. Evaluation of Biofield Energy Treated Vitamin D<sup>3</sup> in Human Osteoblasts Cells
  168. Exploring the Effects of Biofield Energy Treated Vitamin D<sup>3</sup> on Bone Health Parameters in MG-63 Cell Line
  169. The Potential Benefits of Biofield Energy Treated Vitamin D<sub>3</sub> on Bone Mineralization in Human Bone Osteosarcoma Cells (MG-63)
  170. Improved Metabolism of Vitamin D<sub>3</sub> in Human Osteoblasts Cells After Biofield Energy Healing Treatment
  171. An Alternative Approach for the Management of Bone Health: Role of Biofield Energy Healing Treated Vitamin D<sub>3</sub>
  172. Effects of Vitamin D<sub>3</sub> on the Proliferation and Mineralization of Human Osteoblast-Like Cells: Implications of Biofield Energy Healing Treatment
  173. Impact of Biofield Energy Healing Treated Vitamin D<sub>3</sub> on Human Osteoblast Cell Line (MG-63) for Bone Health
  174. Role of Vitamin D<sub>3</sub> on Alkaline Phosphatase, Collagen, and Bone Mineralization: Impact of Biofield Energy Healing Treatment
  175. Biofield Energy Treated Vitamin D<sub>3</sub>: Direct Effect on Bone Health Using Human Osteoblast-Like Cells
  176. <i>In Vitro</i> Effects of Biofield Energy Treated Vitamin D<sub>3</sub> Supplementation on Bone Formation by Osteoblasts Cells
  177. Energy of Consciousness Healing on Growth and Yield of the Plant Stem Cells Culture
  178. Evaluation of the Effect of Consciousness Energy Healing Treatment on Physicochemical and Thermal Properties of Flutamide
  179. Influence of the Biofield Energy Healing Treatment on the Physicochemical and Thermal Properties of Metronidazole
  180. Physicochemical and Thermal Properties of Consciousness Energy Healing Treated Hydroxypropyl -Cyclodextrin
  181. Evaluation of the Effect ofBiofield Energy Treatment on Physicochemical and Thermal Properties of Hydroxypropyl β-Cyclodextrin
  182. Effect of Biofield Energy Treatment on Bone Cell Proliferation and Differentiation for the Assessment of its Potential to Improve Bone Health
  183. Physicochemical and Spectroscopic Characterization of Biofield TreatedButylated Hydroxytoluene
  184. Effect of Biofield Energy Treated Cell Growth Medium on Human Fibroblast Cell Growth for Assessment of Skin Health Promotion Potential
  185. Evaluation of Bone Mineral Density and Biochemical Parameters of Bone Metabolism after Treatment with Biofield Energy Treated Vitamin D3 in MG-63 Cells
  186. An Alternative Therapeutic Approach on Bone Cells Differentiation after Administration of Biofield Energy Treated Vitamin D3 in MG-63 Cell line
  187. Spectral, and Thermal Properties of Sodium Selenate Treated with the Energy of Consciousness
  188. Consciousness Healing Treatment on the Physical, Structural, and Thermal Properties of Zinc Chloride
  189. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  190. Energy Healing Treatment on the Physical, Spectral, and Thermal Properties of Zinc Chloride
  191. Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  192. Structure and Isotopic Abundance Ratio of Magnesium Gluconate Using LC-MS and NMR Spectroscopy
  193. Withania somnifera (Ashwagandha) Root Extract Treated with the Energy of Consciousness
  194. Properties of Sodium Selenate Treated with the Energy of Consciousness (The Trivedi Effect®)
  195. Properties and Isotopic Abundance Ratio of Biofield Energy Treated Magnesium Gluconate
  196. Evaluation of Isotopic Abundance Ratio and Structural Properties of Magnesium Gluconate
  197. Evaluation of Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  198. Evaluation of the Energy of Consciousness Healing Treated Withania somnifera Root Extract
  199. Magnesium Gluconate Treated with the Energy of Consciousness Using LC-MS and NMR Spectroscopy
  200. Withania Somnifera (Ashwagandha) Root Extract Using LC-MS, GC-MS, and NMR Spectroscopy
  201. Physical, Spectroscopic, Thermal and Behavioral Properties of Ashwagandha Root Extract
  202. Physicochemical, Spectral, Thermal and Behavioral Properties of Sodium Selenate
  203. Consciousness Energy Healing Treatment on Withania somnifera Root Extract
  204. Evaluation of the Physicochemical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  205. Evaluation of Skin Protective Effect Using in Vitro Cell Line Models of Biofield
  206. Skin Nourishing Effects of Biofield Energy Healing Treatment Based Herbomineral Formulation
  207. Skin Protective Activity of Consciousness Energy Healing Treatment Based Herbomineral Formulation
  208. The Study of Biofield Energy Treatment Based Herbomineral Formulation in Skin Health and Function
  209. Use of Consciousness Energy Healing Based Herbomineral Formulation for Skin Anti-Aging Strategies
  210. Overall Skin Health Potential of the Biofield Energy Healing Based Herbomineral Formulation
  211. Energy Healing Treatment on Herbomineral Formulation in Different Skin Health Parameters
  212. Biofield Energy Healing Based Herbomineral Formulation: An Emerging Frontier in Cosmetic Medicine
  213. Thermal and Behavioral Properties of the Biofield Energy Healing Treated Sodium Selenate
  214. Physicochemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  215. Structural Characterization and Isotopic Abundance Ratio Analysis of Magnesium Gluconate
  216. Healing Treatment on Physical, Structural, Thermal, and Behavioral Properties of Zinc Chloride
  217. Consciousness Healing Treated Withania Somnifera Root Extract Using LC-MS, GC-MS, and NMR
  218. Withania somnifera Root Extract Using GC-MS and Nuclear Magnetic Resonance Spectroscopy
  219. Physicochemical, Thermal, Structural, and Behavioral Properties Analysis in Magnesium Gluconate
  220. Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate
  221. Solid State Characterization of Withania somnifera (Ashwagandha) Root Extract
  222. Energy Healing Treatment Based Herbomineral Formulation Against Various Skin Health Parameters
  223. Skin Photo-Protective and Anti-ageing Activity of Consciousness Energy Healing Treatment
  224. An in Vitro Study of Biofield Energy Healing Based Herbomineral Formulation for Skin Protection
  225. Immunomodulatory Response of Herbomineral Formulation in Male Sprague Dawley Rats
  226. Novel Herbomineral Formulation After Oral Administration in Male Sprague Dawley Rats
  227. Characterization of the Consciousness Energy Healing Treated Withania somnifera Root Extract
  228. Analysis of Withania somnifera Root Extract After Treatment with the Energy of Consciousness
  229. Differential Regulation of Immune Biomarkers by the The Trivedi Effect® on Herbomineral Formulation
  230. Immunopotentiating Impact of The Trivedi Effect® on Herbomineral Formulation Oral Administration
  231. Evaluation of the Physico-chemical, Thermal and Behavioral Properties of Ashwagandha Root Extract
  232. Impact of Trivedi Effect® on Physicochemical, Thermal, Properties of Magnesium Gluconate
  233. Evaluation of Immunomodulatory Properties After Oral Administration of Biofield Energy Treated Test Formulation in <i>Sprague Dawley</i> Rats: Influence of the Trivedi Effect<sup>®</sup>
  234. Evaluation of the Effects of Biofield Energy Healing Based Herbomineral Formulation on Various Biomarkers in Male <i>Sprague Dawley</i> Rats: Potential Role of the Trivedi Effect<sup>®</sup>
  235. Characterization of Physicochemical, Thermal, Structural, and Behavioral Properties of Magnesium Gluconate After Treatment with the Energy of Consciousness
  236. Evaluation of Immune Biomarkers After Oral Administration of the Novel Herbomineral Formulation Treated with The Trivedi Effect<sup>®</sup> - Biofield Energy Healing in Male <i>Sprague Dawley</i> Rats
  237. Immunomodulatory Activity of Biofield Energy Healing Based Herbomineral Formulation in <i>Sprague Dawley</i> Rats: Evidence for Humoral and Cell-Mediated Responses
  238. An Investigation of The Trivedi Effect<sup>®</sup>-Energy of Consciousness Healing Treatment to Modulate the Immunomodulatory Effect of Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  239. Assessment of Consciousness Energy Healing Treatment on Immune Biomarkers After Oral Administration of Herbomineral Formulation in <i>Sprague Dawley</i> Male Rats
  240. Evaluation of Immune Biomarkers After Oral Administration of Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  241. Evaluation of Immunomodulatory Parameters in Female <i>Sprague Dawley</i> Rats after Oral Administration of the Biofield Energy Healing Treated Herbomineral Formulation
  242. Impact of Biofield Treated Formulation on Immune Biomarkers of Female Sprague Dawley Rats
  243. Investigation of Immune Biomarkers Regulation by Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rats
  244. Modulation of Immune Biomarkers by Biofield Energy Healing Based Herbomineral Formulation in Male <i>Sprague Dawley</i> Rat: Potential Role of Energy of Consciousness
  245. Effect of Biofield Energy Healing (The Trivedi Effect<sup>®</sup>) Based Novel Herbomineral Formulation on Immune Biomarkers After Oral Administration in Female <i>Sprague Dawley</i> Rats
  246. Immunomodulatory Potential of New Classical Herbomineral Formulation in Experimental Animals: Impact of Biofield Energy Healing Treatment
  247. Assessment of Immunomodulatory Activity of the Biofield Energy Treated Novel Herbomineral Formulation After Oral Administration in Female <i>Sprague Dawley</i> Rats
  248. Characterization of the Physicochemical, Structural, and Thermal Properties of Zinc Chloride After the Consciousness Energy Healing Treatment
  249. Implication of Biofield Energy Healing Based Vitamin D3 on Osteoblastic Differentiation
  250. Improved Bone Health Parameters After Treatment with Consciousness Energy Treated Vitamin D3
  251. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Treated Ortho-Toluic Acid
  252. Biochemical Reactions, and Genotypic Pattern of Biofield Treated Pseudomonas aeruginosa
  253. Thermal, Spectroscopic and Chemical Characterization of Biofield Energy Treated Anisole
  254. Biofield Energy Treated Nitrophenol Derivatives Using Gas Chromatography-Mass Spectrometry
  255. Physicochemical Characterization of Biofield Energy Treated Hi VegTM Acid Hydrolysate
  256. 1,2,3-Trimethoxybenzene (TMB) After Biofield Energy Treatment (The Trivedi Effect®) Using GC-MS
  257. Biofield Energy Treated Resorcinol Using Gas Chromatography-Mass Spectrometry Technique
  258. Isotopic Abundance of 2H, 13C, 18O, and 37Cl in Biofield Energy Treated Dichlorophenol Isomers
  259. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Indole Using GC-MS
  260. 13C/12C or 2H/1H and 18O/16O in Biofield Energy Treated 1-Chloro-3-Nitrobenzene (3-CNB) Using GC-MS
  261. Isotopic Abundance of 13C, 2H, and 18O in Biofield Energy Treated p-tertiary Butylphenol (PTBP)
  262. Isotopic Abundance Ratio Analysis of Biofield Energy Treated Methyl-2-napthylether (Nerolin)
  263. Biofield Energy Treated 1,4-Dichlorobenzene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  264. Biofield Energy Healing (The Trivedi Effect®) Based Herbomineral Formulation in Mouse Splenocytes
  265. Evaluation Mouse Splenocytes After Co-Incubation with the Biofield Energy Treated Formulation
  266. Mouse Splenocyte Cells After Incubation with Biofield Energy Healing Based Herbomineral Formulation
  267. Impact of the Trivedi Effect Herbomineral Formulation on Pro-inflammatory Cytokines Expression
  268. Pro-Inflammatory Cytokines Expression in Murine Dendritic and Splenocyte Cells
  269. Mouse Splenocytes After Incubation with Biofield Treated Herbomineral Formulation
  270. Mouse Dendritic and Splenocyte Cells for Modulation of Pro-inflammatory Cytokines
  271. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Ammonium Acetate and Ammonium Chloride: An Impact of Biofield Treatment
  272. Characterization of Physical, Thermal and Structural Properties of Chromium (VI) Oxide Powder: Impact of Biofield Treatment
  273. Characterization of Physical, Spectral and Thermal Properties of Biofield Treated 1,2,4-Triazole
  274. Antibiogram Typing and Biochemical Characterization of Klebsiella pneumoniae after Biofield Treatment
  275. Physical, Thermal and Spectroscopic Characterization of m-Toluic Acid: an Impact of Biofield Treatment
  276. Fourier Transform Infrared and Ultraviolet-Visible Spectroscopic Characterization of Biofield Treated Salicylic Acid and Sparfloxacin
  277. Physical and Structural Characterization of Biofield Treated Imidazole Derivatives
  278. Evaluation of Physical, Thermal and Spectroscopic Properties of Biofield Treated p-Hydroxyacetophenone
  279. Characterization of Physico-Chemical and Spectroscopic Properties of Biofield Energy Treated 4-Bromoacetophenone
  280. Physicochemical and Spectroscopic Characterization of Biofield Treated Triphenyl Phosphate
  281. Physical and Structural Characterization of Biofield Energy Treated Carbazole
  282. Evaluation of Biofield Treatment on Atomic and Thermal Properties of Ethanol
  283. Characterisation of Physical, Spectral and Thermal Properties of Biofield treated Resorcinol
  284. Physicochemical and Atomic Characterization of Silver Powder after Biofield Treatment
  285. Spectroscopic Characterization of Disodium Hydrogen Orthophosphate and Sodium Nitrate after Biofield Treatment
  286. Characterization of Physical and Structural Properties of Aluminium Carbide Powder: Impact of Biofield Treatment
  287. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii: A Urinary Pathogen
  288. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Methyl-2-Naphthyl Ether
  289. Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment
  290. Physical, Thermal and Spectral Properties of Biofield Treated 1,2,3-Trimethoxybenzene
  291. Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen
  292. Physical, Thermal and Spectroscopic Characterization of Biofield Treated p-Chloro-m-cresoln
  293. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2, 6-Diaminopyridine
  294. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated O-Aminophenol
  295. Characterization of Physicochemical and Thermal Properties of Chitosan and Sodium Alginate after Biofield Treatment
  296. Biofield Energy Treatment: A Potential Strategy for Modulating Physical, Thermal and Spectral Properties of 3-Chloro-4-fluoroaniline
  297. The Potential Impact of Biofield Energy Treatment on the Physical and Thermal Properties of Silver Oxide Powder
  298. Physical and Thermal Properties of O-Nitrophenol, M-Nitrophenol and P-Tertiary Butyl Phenol
  299. Antibiogram Pattern of Shigella flexneri: Effect of BioField Treatment
  300. Physical, Thermal and Spectral Properties of Biofield Energy Treated 2,4-Dihydroxybenzophenone
  301. Characterization of Physical, Thermal and Spectroscopic Properties of Biofield Energy Treated p-Phenylenediamine and p-Toluidine
  302. Characterization of Phenotype and Genotype of Biofield Treated Enterobacter aerogenes
  303. Evaluation of Antibiogram, Genotype and Phylogenetic Analysis of Biofield Treated Nocardia otitidis
  304. Potential Impact of BioField Treatment on Atomic and Physical Characteristics of Magnesium
  305. Evaluation of Thermal and Physical Properties of Magnesium Nitride Powder: Impact of Biofield Energy Treatment
  306. Influence of Biofield Treatment on Physical and Structural Characteristics of Barium Oxide and Zinc Sulfide
  307. Antibiogram and Genotypic Analysis using 16S rDNA after Biofield Treatment on Morganella morganii
  308. Investigation of Biofield Treatment on Antimicrobial Susceptibility, Biochemical Reaction Pattern and Biotyping of Enteropathogenic Multidrug-Resistant Escherichia coli Isolates
  309. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using Gas Chromatography-Mass Spectrometry (GC-MS)
  310. Assessment of Antibiogram of Multidrug-Resistant Isolates of Enterobacter aerogenes after Biofield Energy Treatment
  311. Characterization of Biofield Energy Treated 3-Chloronitrobenzene: Physical, Thermal, and Spectroscopic Studies
  312. Impact of Biofield Energy Treatment on Soil Fertility
  313. Influence of Biofield Energy Treatment on Isotopic Abundance Ratio in Aniline Derivatives
  314. Studies on Physicochemical Properties of Biofield Treated 2,4-Dichlorophenol
  315. Physical, Thermal, and Spectroscopic Characterization of Biofield Energy Treated Potato Micropropagation Medium
  316. Evaluation of Biofield Treated Peptone And Malmgren Modified Terrestrial Orchid Medium
  317. Physical, Thermal and Spectral Properties of Biofield Treated 3-Nitroacetophenone
  318. Thermal, Spectroscopic and Chromatographic Characterization of Biofield Energy Treated Benzophenone
  319. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2-Aminopyridine
  320. Characterization of Physical, Spectroscopic and Thermal Properties of Biofield Treated Biphenyl
  321. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated 2,6-Dichlorophenol
  322. Physicochemical and Spectral Characterization of Biofield Energy Treated 4-Methylbenzoic Acid
  323. Chromatographic, Spectroscopic, and Thermal Characterization of Biofield Energy Treated N,N-Dimethylformamide
  324. Physicochemical Characterization of Biofield Energy Treated Calcium Carbonate Powder
  325. Molecular Analysis of Biofield Treated Eggplant and Watermelon Crops
  326. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated p-Anisidine
  327. Characterization of Physical and Thermal Properties of Biofield Treated Neopentyl glycol
  328. Physical, Thermal and Spectral Parameters of Biofield Energy Treated Methylsulfonylmethane
  329. Antibiogram Typing of Biofield Treated Multidrug Resistant Strains of Staphylococcus Species
  330. Analysis of Physical, Thermal, and Structural Properties of Biofield Energy Treated Molybdenum Dioxide
  331. Physical and Structural Properties of Calcium Carbide and Praseodymium Oxide
  332. Physicochemical and Spectroscopic Characteristics of Biofield Treated p-Chlorobenzophenone
  333. Characterization of Physical, Thermal and Spectral Properties of Biofield Treated Date Palm Callus Initiation Medium
  334. Biofield Energy Treatment on Physical and Thermal Characteristics of Selenium Powder
  335. Morphological Characterization, Quality, Yield & DNA Fingerprinting of Energy Treated Alphonso Mango
  336. Escherichia coli for Antimicrobial Susceptibility, Biochemical Reaction and Biotyping
  337. Evaluation of Isotopic Abundance Ratio in Naphthalene Derivatives After Biofield Energy Treatment
  338. Improved Susceptibility Pattern of Antimicrobials Using Vital Energy Treatment on Shigella sonnei
  339. Biochemical Differentiation & Molecular Characterization of Biofield Treated Vibrio parahaemolyticus
  340. Physical, Thermal and Spectroscopical Characterization of Biofield Treated Triphenylmethane: An Impact of Biofield Treatment
  341. Experimental Investigation on Physical, Thermal and Spectroscopic Properties of 2-Chlorobenzonitrile: Impact of Biofield Treatment
  342. Characterization of Biofield Energy Treated Murashige and Skoog Plant Cell Culture Media
  343. Physicochemical and Spectroscopic Characterization of Yeast Extract Powder After the Biofield Energy Treatment
  344. Physical, Spectroscopic and Thermal Characterization of Biofield Treated Fish Peptone
  345. Physicochemical and Spectroscopic Properties of Biofield Energy Treated Protose
  346. Physicochemical and Spectroscopic Characterization of Biofield Energy Treated Gerbera Multiplication Medium
  347. Biofield Treated Phosphate Buffer Saline and Hanks Balanced Salt Medium
  348. Characterization of Physicochemical and Spectroscopic Properties of Biofield Energy Treated Bio Peptone
  349. Spectral and Thermal Properties of Biofield Energy Treated Cotton
  350. Effect of Biofield Treated Energized Water on the Growth and Health Status in Chicken
  351. Characterization of Atomic and Physical Properties of Biofield Energy Treated Manganese Sulfide Powder
  352. Assessment of Antibiogram of Biofield Energy Treated Serratia marcescens
  353. Biofield Treatment on Viral Load Against Human Immunodeficiency-1 and Cytomegalo Viruses
  354. Antibiogram, Biochemical Reactions and Biotyping of Biofield Treated Providencia rettgeri
  355. Isotopic Abundance Analysis of Biofield Treated Benzene, Toluene and p-Xylene Using GC-MS
  356. Phenotyping and Genotyping Characterization of Proteus vulgaris After Biofield Treatment
  357. Plant Growth Regulator, Immunity and DNA Fingerprinting of Biofield Energy Treated Mustard Seeds
  358. Agronomic Characteristics, Growth Analysis, and Yield Response of Biofield Treated Mustard, Cowpea, Horse Gram, and Groundnuts
  359. Physical, Thermal and Spectroscopic Studies of Biofield Treated p-Chlorobenzonitrile
  360. Effect of Biofield Treatment on Physical, Thermal, and Spectral Properties of SFRE 199-1 Mammalian Cell Culture Medium
  361. Biochemical Marker – Glutathione and DNA Fingerprinting of Biofield Energy Treated Oryza sativa
  362. Antibiogram of Biofield-Treated Shigella boydii: Global Burden of Infections
  363. Morphological and Molecular Analysis Using RAPD in Biofield Treated Sponge and Bitter Gourd
  364. Antibiogram, Biochemical Reactions and Genotyping Characterization of Biofield Treated <i>Staphylococcus aureus</i>
  365. Isotopic Abundance of 13C, 2H, or 15N in Biofield Energy Treated Aminopyridine Derivatives
  366. Vegetative Growth Parameters in Biofield Treated Bottle Gourd (Lagenaria siceraria) & Okra
  367. Genetic Diversity Using SSR Markers & Growth Regulator Response in Biofield Treated Cotton
  368. Ratio of 13C, 2H, and 18O in Biofield Energy Treated Ortho and Meta Toluic Acid Isomers
  369. Plant Growth, Yield and Yield Attributes of Biofield Energy Treated Mustard and Chick Pea Seeds
  370. Antimicrobial Susceptibility of Proteus mirabilis: Impact of Biofield Energy Treatment
  371. Bacterial Identification Using 16S rDNA Gene Sequencing and Antibiogram Analysis on Biofield Treated Pseudomonas fluorescens
  372. Impact of Biofield Treatment on Spectroscopic and Physicochemical Properties of p-Nitroaniline
  373. Physicochemical and Spectroscopic Characterization of p-Chlorobenzaldehyde: An Impact of Biofield Energy Treatment
  374. Evaluation of Atomic, Physical and Thermal Properties of Tellurium Powder: Impact of Biofield Energy Treatment
  375. Antibiogram of Multidrug-Resistant Isolates of Pseudomonas aeruginosa after Biofield Treatment
  376. Characterization of Antimicrobial Susceptibility Profile of Biofield Treated Multidrug-resistant Klebsiella oxytoca
  377. Phenotyping and 16S rDNA Analysis after Biofield Treatment on Citrobacter braakii
  378. Antimicrobial Susceptibility, Biochemical Characterization and Molecular Typing of Biofield Treated Klebsiella pneumoniae
  379. Modification of Physical and Thermal Properties of Gluten Hydrolysate and Ipomoea Macroelements
  380. Investigation of Isotopic Abundance Ratio of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry
  381. Physical, Atomic and Thermal Properties of Biofield Treated Lithium Powder
  382. Potential Impact of Biofield Energy Treatment on the Atomic, Physical and Thermal Properties Indium Powder
  383. Physical, Spectroscopic and Thermal Characterization of Biofield treated Myristic acid
  384. Physical, Thermal and Spectroscopic Studies on Biofield Treated p-Dichlorobenzene
  385. Antimicrobial Susceptibility Pattern, Biochemical Characteristics and Biotyping of Salmonella paratyphi A: An Impact of Biofield Treatment
  386. Spectroscopic Characterization of Disulfiram and Nicotinic Acid after Biofield Treatment
  387. Biofield Treatment: A Potential Strategy for Modification of Physical and Thermal Properties of Indole
  388. In Vitro Evaluation of Antifungal Sensitivity Assay of Biofield Energy Treated Fungi